rs5030865
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 2 | CYP2D6*8 inactive type homozygote |
(A;C) | 2 | carrier of one CYP2D6*8 inactive type allele |
(A;T) | 2 | carrier of one CYP2D6*8 and one CYP2D6*14 inactive type alleles |
(C;C) | 1 | normal |
(C;T) | 2 | carrier of one CYP2D6*14 inactive type allele |
(T;T) | 2 | CYP2D6*14 inactive type homozygote |
Reference | GRCh37 37.1/131 |
Chromosome | 22 |
Position | 42129033 |
Gene | CYP2D6, LOC102723722, LOC107987465, LOC107987481 |
is a | snp |
is | mentioned by |
dbSNP | rs5030865 |
dbSNP (classic) | rs5030865 |
ClinGen | rs5030865 |
ebi | rs5030865 |
HLI | rs5030865 |
Exac | rs5030865 |
Gnomad | rs5030865 |
Varsome | rs5030865 |
LitVar | rs5030865 |
Map | rs5030865 |
PheGenI | rs5030865 |
Biobank | rs5030865 |
1000 genomes | rs5030865 |
hgdp | rs5030865 |
ensembl | rs5030865 |
geneview | rs5030865 |
scholar | rs5030865 |
rs5030865 | |
pharmgkb | rs5030865 |
gwascentral | rs5030865 |
openSNP | rs5030865 |
23andMe | rs5030865 |
SNPshot | rs5030865 |
SNPdbe | rs5030865 |
MSV3d | rs5030865 |
GWAS Ctlg | rs5030865 |
GMAF | 0.0009183 |
Max Magnitude | 2 |
rs5030865 is a SNP in the CYP2D6 gene which defines two inactive variants, CYP2D6*8 and CYP2D6*14. This SNP has changed orientation in different reference genome builds and also has more than two allele changes possible, so references to it can be very confusing. The below are in genome build 37.1 plus orientation, while the "also knowns" are in minus orientation:
rs5030865(C) is the normal variant
rs5030865(A) is the CYP2D6*8 inactive variant, also known as 1758G>T or G169X
rs5030865(T) is the CYP2D6*14 inactive variant, also known as 1758G>A or G169R
ClinVar | |
---|---|
Risk | Rs5030865(A;A) Rs5030865(T;T) |
Alt | Rs5030865(A;A) Rs5030865(T;T) |
Reference | Rs5030865(C;C) |
Significance | Drug-response |
Disease | Debrisoquine |
Variation | info |
Gene | CYP2D6 |
CLNDBN | Debrisoquine, poor metabolism of |
Reversed | 0 |
HGVS | NC_000022.10:g.42525035C>A |
CLNSRC | OMIM Allelic Variant |
CLNACC | RCV000018388.29, |
[PMID 18547414] Genotyping panel for assessing response to cancer chemotherapy.